160929 post nl presentation molecule to business

Bringing care homeMolecule to BusinessHuub Zijlstra -

Business Development Manager Healthcare

PostNL

Help patients in their

favorite environment

Mission

Economical Climate:

Pressure on costs in

Care & Cure

Aging, more health

needs

Renewed GDP

guidelines

Empowered patients

Personal medicines

Higher influence of

insurance

Merges in the sector

More high value medication

More Care & Cure at home

Developments & trends

Today

Every customer

is unique,

including the

distribution

requirements

Parcels

PostNL Pakketten

Pallets & Rolcages

PostNL Cargo

Behind the door

Extra@Home

Secured

Mikropakket

Courier

Valid Express

Temperature controlled

Pharma & Care

B2C fulfilment

Ecommerce Services

Regulation

1. Dutch Law: “Geneesmiddelenwet”

“handover” only by pharmacist (or doctor by exception)

2. GDP EU regulations (Good Distributions Practices):

• European perspective

• Dutch Healthcare Inspectorate

3. Pharmacist “standard”

Samenwerking

Orly Pharma & PostNL

What is important to OrlyPharma ?

1. GDP Compliancy

2. Price

3. Leadtimes

4. Temperature monitoring & qualitysystem

Good Distribution Practices (GDP)

“The required storage conditions for medicinal products

should be maintained during transportation within the

defined limits as described by the manufacturers or on the

outer packaging.” GDP regulation, nov 2013, EU

Patient empowerment

Personal preferences

Patient journey

Health vs Logistics

Standard-

isation

High

educated

personal

Focus on

processProduct

knowledge

Co

mm

un

icatio

n

https://nl.linkedin.com/in/huubzijlstra

https://twitter.com/huubzijlstra

Business Development

Manager Healthcare

T: +31-622726810

E: huub.zijlstra@postnl.nl

Thank you for your

attention Feel free to ask questions

and hopefully we meet along the

ride